| Literature DB >> 36153370 |
Weimei Tang1, Miaomiao Pei1, Jiaying Li1, Nanzhu Xu1, Wushuang Xiao1, Zhen Yu1, Jieming Zhang1, Linjie Hong1, Zheng Guo2, Jianjiao Lin3, Weiyu Dai1, Yizhi Xiao1, Xiaosheng Wu1, Guangnan Liu1, Fachao Zhi1,3, Guoxin Li4, Jing Xiong1, Ye Chen5, Hui Zhang6, Li Xiang7, Aimin Li8, Side Liu9,10, Jide Wang11,12.
Abstract
Although the abnormal expression of miRNAs in cancer cells is a widely accepted phenomenon, the molecular mechanisms underlying miR-3648 progression and metastasis in gastric cancer (GC) remain unclear. miR-3648 expression is downregulated and its ectopic expression in GC cells significantly suppressed cell proliferation and metastasis. Mechanistic analyses indicated that miR-3648 directly targets FRAT1 or FRAT2 and inhibits FRAT1- or FRAT2-mediated invasion and motility in vitro and in vivo. Moreover, FRAT1 physically interacted with FRAT2. Furthermore, FRAT1 overexpression promoted GC cell invasion, whereas siRNA-mediated repression of FRAT2 in FRAT1-overexpressing GC cells reversed its invasive potential. Besides, miR-3648 inactivated the Wnt/β-catenin signalling pathway by downregulating FRAT1 and FRAT2 in GC. Interestingly, c-Myc, a downstream effector of Wnt/β-catenin signalling, was also downregulated by miR-3648 overexpression. In turn, c-Myc negatively regulated miR-3648 expression by binding to the miR-3648 promoter. In addition, miR-3648 expression levels were negatively correlated with c-Myc, FRAT1, and FRAT2 expression in fresh gastric samples. Our studies suggest that miR-3648 acts as a tumour-suppressive miRNA and that the miR-3648/FRAT1-FRAT2/c-Myc negative feedback loop could be a critical regulator of GC progression.Entities:
Year: 2022 PMID: 36153370 PMCID: PMC9586869 DOI: 10.1038/s41388-022-02451-2
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 8.756